These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1737378)
1. Growth-inhibitory action of an estrogen-chlorambucil conjugate (KM2210) in human breast cancer cell line MCF-7: its relation to reduction of estrogen receptor and transforming growth factor-alpha secretion. Kosano H; Kubota T; Ohsawa N; Yamamori S; Abe O; Inagaki H; Nagata N Cancer Res; 1992 Mar; 52(5):1187-91. PubMed ID: 1737378 [TBL] [Abstract][Full Text] [Related]
2. Mode of action of estra-1,3,5(10)-triene-3, 17 beta-diol, 3-benzoate, 17[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy] acetate] (KM2210) on MCF-7 human breast tumours transplanted into nude mice. Kubota T; Ishibiki K; Abe O; Kosano H; Ohsawa N; Hoffman RM Anticancer Res; 1993; 13(4):935-40. PubMed ID: 8352562 [TBL] [Abstract][Full Text] [Related]
3. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth. Herman ME; Katzenellenbogen BS Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid. Kosano H; Yasutomo Y; Kugai N; Nagata N; Inagaki H; Tanaka S; Takatani O Cancer Res; 1990 Jun; 50(11):3172-5. PubMed ID: 2334912 [TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein. Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268 [TBL] [Abstract][Full Text] [Related]
6. Retinoid antagonism of estrogen-responsive transforming growth factor alpha and pS2 gene expression in breast carcinoma cells. Fontana JA; Nervi C; Shao ZM; Jetten AM Cancer Res; 1992 Jul; 52(14):3938-45. PubMed ID: 1319834 [TBL] [Abstract][Full Text] [Related]
7. Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells. Kenney NJ; Saeki T; Gottardis M; Kim N; Garcia-Morales P; Martin MB; Normanno N; Ciardiello F; Day A; Cutler ML J Cell Physiol; 1993 Sep; 156(3):497-514. PubMed ID: 8360257 [TBL] [Abstract][Full Text] [Related]
8. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Swami S; Krishnan AV; Feldman D Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825 [TBL] [Abstract][Full Text] [Related]
9. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7. Butler WB; Fontana JA Cancer Res; 1992 Nov; 52(22):6164-7. PubMed ID: 1423259 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells. Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803 [TBL] [Abstract][Full Text] [Related]
11. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Miller MA; Lippman ME; Katzenellenbogen BS Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Danforth DN; Sgagias MK Cancer Res; 1993 Apr; 53(7):1538-45. PubMed ID: 8453620 [TBL] [Abstract][Full Text] [Related]
13. Induction of jun gene family members by transforming growth factor alpha but not 17 beta-estradiol in human breast cancer cells. Davidson NE; Prestigiacomo LJ; Hahm HA Cancer Res; 1993 Jan; 53(2):291-7. PubMed ID: 8417822 [TBL] [Abstract][Full Text] [Related]
14. Growth factors and chemotherapeutic modulation of breast cancer cells. Ciftci K; Su J; Trovitch PB J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells. Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041 [TBL] [Abstract][Full Text] [Related]
16. [Quantitative assay of growth response of clinical breast cancer cells against E2 or E2-conjugated drugs]. Matsuoka H; Furusawa M; Sugimachi K Gan To Kagaku Ryoho; 1994 Aug; 21(10):1705-6. PubMed ID: 8060151 [No Abstract] [Full Text] [Related]
17. Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression. Reddy KB; Yee D; Hilsenbeck SG; Coffey RJ; Osborne CK Cell Growth Differ; 1994 Dec; 5(12):1275-82. PubMed ID: 7696176 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide. Eppstein DA; Marsh YV; Schryver BB; Bertics PJ J Cell Physiol; 1989 Nov; 141(2):420-30. PubMed ID: 2530243 [TBL] [Abstract][Full Text] [Related]
19. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression. Sheikh MS; Shao ZM; Chen JC; Li XS; Hussain A; Fontana JA J Cell Biochem; 1994 Mar; 54(3):289-98. PubMed ID: 8200909 [TBL] [Abstract][Full Text] [Related]
20. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines. ter Haar E; Day BW Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]